Definitive Contract HHSN271200588551C

This is a $1,299,218.00 Definitive Contract awarded by the Food and Drug Administration (FDA) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for "BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS" and has a period of performance through February 2, 2026. The contract is a Time and Materials type with no set-aside designation. PPD...

The Emmes Company LLC was awarded a cost-plus-fixed-fee delivery order contract valued at $881,366 by the National Institutes of Health's National Institute on Drug Abuse to conduct a randomized clinical trial of clinical decision support for opioid use disorders in medical settings. The contract is being carried out under the National Institute on Drug Abuse's Data, Statistics, and Clinical Trial Support Center program and will involve The Emmes Company LLC performing work in Potomac,...

This is a $1,406,983.00 cost-plus-fixed-fee delivery order contract awarded to The Emmes Company LLC by the National Institute on Drug Abuse (NIDA), a civilian agency, to provide data, statistics, and clinical trial support center management and support services. The work is being performed under Task Order 75N95021F00004 (TO23) of NIDA's $31.2 million Data, Statistics, and Clinical Trial Support Center Management and Support indefinite delivery contract, awarded without a set-aside designation....

This is a $3,973,303.00 delivery order awarded by the National Library of Medicine (part of the Department of Health and Human Services) to ICF Incorporated, L.L.C., a global consulting and technology services company. The delivery order provides operations, maintenance, and modernization support for the ClinicalTrials.gov website, which is a database of privately and publicly funded clinical studies conducted around the world. The contract is not set aside for any specific business type and...

This is a Firm Fixed Price Delivery Order awarded by the Department of the Army Medical Command to PPD Development LP, a global contract research organization (CRO), for the development of a U.S. Army Blood Products and Components Concept of Operations (CONOPS) for Damage Control Resuscitation (DCR). The contract has a potential value of $462,762.35 and was not set aside for any specific business type. The order falls under the broader Medical Product Research and Development Indefinite Delivery...

This is a $317,148,294.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business based in Bethesda, Maryland. The contract is for clinical trial planning and execution services in support of the Clinical Services Network, with an ultimate completion date of August 21, 2028. This contract is not set...

This is a $1,859,402 task order award under the National Institute of Allergy and Infectious Diseases' (NIAID) Early Phase Clinical Trial Units (EPCTU) indefinite delivery vehicle (IDV) contract. The prime contractor, PPD Development LP, is a global contract research organization that provides comprehensive clinical trial and research support services to federal agencies. This cost-plus-fixed-fee delivery order does not have a set-aside designation. PPD will perform the work in Cape Fear,...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $500,263.64 Delivery Order contract to PPD Development LP, a global contract research organization (CRO), for clinical site and study monitoring services in support of research partnerships for global mental health. The contract has a period of performance from September 28, 2018 to September 27, 2023 and is a labor hours type contract. PPD Development LP has provided over $500...

This is a $222,126,308 cost-plus-incentive federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The contract is for a randomized, double-blind, placebo-controlled, multicenter Phase 2 clinical trial in the U.S. to evaluate the safety and efficacy of novel host-directed therapeutic candidates in hospitalized adults with...

This $31,180,157.02 federal contract award was issued by the National Heart Lung and Blood Institute, part of the National Institutes of Health, to Wake Forest University Health Sciences (WFUHS) to serve as the Coordinating Center for the ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES FOLLOW-ON (ACCORDION) STUDY. The ACCORDION study is a prospective observational follow-up of approximately 8,000 participants from the earlier ACCORD clinical trial on cardiovascular risk factors in diabetes....